BRII-B(02137),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02137 BRII-B

Not Yet Opened 09-14 16:08:02

0.880

-0.010

-1.12%

High0.930	Low0.855	Vol773.50K
Open0.930	D1 Closing0.890	Amplitude8.43%
Mkt Cap635.36M	Tradable Cap635.36M	Total Shares722.00M
T/O672.44K	T/O Rate0.11%	Tradable Shares722.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02137","market":"HK","secType":"STK","nameCN":"BRII-B","latestPrice":0.88,"timestamp":1789373282313,"preClose":0.89,"halted":0,"volume":773500,"delay":0,"changeRate":-0.011235955056179785,"floatShares":722000000,"shares":722000000,"eps":-0.36056530541589865,"marketStatus":"Not Yet Opened","change":-0.01,"latestTime":"09-14 16:08:02","open":0.93,"high":0.93,"low":0.855,"amount":672437,"amplitude":0.08427,"askPrice":0.88,"askSize":5500,"bidPrice":0.87,"bidSize":10000,"shortable":0,"etf":0,"ttmEps":-0.2815114116004549,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":0,"adr":0,"listingDate":1626105600000,"exchange":"SEHK","adjPreClose":0.89,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"volumeRatio":1.412579,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02137","defaultTab":"news","newsList":[{"id":"1174024704","title":"Brii Biosciences Completes Additional Share Buyback; Treasury Stock Rises to 12.92 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1174024704","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174024704?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:41","pubTimestamp":1788183687,"startTime":"0","endTime":"0","summary":"Hong Kong-listed Brii Biosciences Limited executed a further on-market repurchase of 20,000 ordinary shares on 31 August 2026, paying an aggregate HK$0.02 million at prices between HK$0.905 and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006385","title":"Brii Biosciences Files HKEX Next-Day Disclosure Return on Share Repurchase for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006385","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663006385?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:21","pubTimestamp":1788182514,"startTime":"0","endTime":"0","summary":"Brii Biosciences files HKEX next-day disclosure return on share repurchase for cancellationBrii Biosciences repurchased 20,000 ordinary shares on Aug. 31 for treasury, with no shares cancelled.Buyback","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL3NWc5r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","BK1161","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136334991","title":"HK Movers | Biotech Stocks Jump. CANSINOBIO Surges 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136334991","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136334991?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:47","pubTimestamp":1787708820,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong market. CANSINOBIO surged 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%.On the news front, $CANSINOBIO(06185)$ announced on August 25 that its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06606","09995","02268","09606","06978","02359","02137","02269","01672","03347","09688","03759","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138316242","title":"Brii Bio Repurchases 120,000 Shares; Treasury Stock Rises to 12.90 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1138316242","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138316242?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:27","pubTimestamp":1787660829,"startTime":"0","endTime":"0","summary":"Brii Biosciences Limited (BRII-B) executed an on-market buyback of 120,000 ordinary shares on 25 August 2026, paying between HKD 0.995 and HKD 1.03 per share for a total consideration of HKD 0.12...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153751437","title":"Brii-Biosciences (BRII-B) Issues 0.26 Million New Shares Under Employee Schemes; Repurchases 0.06 Million Shares Into Treasury","url":"https://stock-news.laohu8.com/highlight/detail?id=1153751437","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153751437?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:47","pubTimestamp":1787582867,"startTime":"0","endTime":"0","summary":"Brii Biosciences Limited (BRII-B) reported several capital movements between 10 and 24 August 2026 that marginally expanded its share base while strengthening its treasury stock position. The company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113970719","title":"BRII-B (02137) Buys Back 60,000 Shares for HK$60,300 on August 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1113970719","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113970719?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:34","pubTimestamp":1787582054,"startTime":"0","endTime":"0","summary":"BRII-B (02137) has announced that on August 24, 2026, the company spent HK$60,300 to repurchase 60,000 of its own shares.The buyback reflects the company's ongoing capital management strategy, as it...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02137","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661747952","title":"Brii Biosciences Files HKEX Next-Day Disclosure, Lifts Share Capital by 255,793 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2661747952","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661747952?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:18","pubTimestamp":1787581119,"startTime":"0","endTime":"0","summary":"Brii Biosciences files HKEX next-day disclosure, lifts share capital by 255,793 sharesBrii Biosciences filed a next-day disclosure return covering share issuances from option exercises and RSU vesting","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL66JBkW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1587","02137","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661241804","title":"Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2661241804","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661241804?lang=en_us&edition=fundamental","pubTime":"2026-08-24 08:02","pubTimestamp":1787529767,"startTime":"0","endTime":"0","summary":"Sinopharm interim revenue edges down on softness in pharmaceutical distribution businessOverviewChina pharmaceutical distributor's interim revenue declined slightly year-on-yearNet income attributable","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44K04V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","HK0000320264.USD","HK0000306685.HKD","HK0000306701.USD","HK0000320223.HKD","LU0640798160.USD","LU1115378108.SGD","02137","EDMCQ","BK1574","00656","BK1500","BK1161","BK1515","01099","HK0000165453.HKD","BK1197","BK4204","BK1587","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661901362","title":"Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2661901362","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661901362?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:15","pubTimestamp":1787346928,"startTime":"0","endTime":"0","summary":"Niki BioSolutionsweighs financing options as going-concern warning clouds post-merger outlookOverviewUS biopharmaceutical developer's H1 net loss widened, with loss per share at $1.6Operating expenses","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02137","BK1515","IE00BZ08YS42.EUR","BK1583","BK1161","HK0000165453.HKD","BK1521","IE00BZ08YT58.USD","BK1574","BK4139","BK1589","NIKI","06996","IE00BZ08YR35.GBP","01177","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264711","title":"Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264711","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264711?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:38","pubTimestamp":1787308735,"startTime":"0","endTime":"0","summary":"Biotech firm Antengene's H1 revenue jumps on licensing dealsOverviewBiotech company's H1 revenue rose sharply on licensing deals with UCB, K2 TherapeuticsCompany swung to H1 net profit from loss a yea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0AK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1587","BK1161","02137","BK1583","06996","06855","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179632017","title":"Hong Kong Stock Market Flash: BRII-B Surges Over 8% as Interim Loss Narrows 32.08% and Promising Clinical Data Emerges","url":"https://stock-news.laohu8.com/highlight/detail?id=1179632017","media":"Stock News","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179632017?lang=en_us&edition=fundamental","pubTime":"2026-08-21 11:41","pubTimestamp":1787283672,"startTime":"0","endTime":"0","summary":"Shares of BRII-B (02137) climbed more than 8% before the midday break, trading up 8.16% at HK$1.06 with turnover reaching HK$52.37 million.The company released its interim results for the six months...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","VXUS","BK4585","BK1161","BK4588","BK1587","02137","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661125866","title":"China's Brii Biosciences Interim Net Loss Narrows on Lower R&D Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2661125866","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661125866?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:14","pubTimestamp":1787267641,"startTime":"0","endTime":"0","summary":"China's Brii Biosciences interim net loss narrows on lower R&D expensesOverviewChina biotech firm's interim net loss narrowed for six months ended June 30, 2026Lower R&D and administrative expenses co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H13O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","02137","BK1587","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661638258","title":"Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2661638258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661638258?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:10","pubTimestamp":1787267400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUABLCVSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","BK1587","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661325830","title":"Brii Biosciences: Hy Other Income Rmb19.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2661325830","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661325830?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:02","pubTimestamp":1787266922,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXMQ7KNH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","02137","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258376","title":"Brii Bio H1 FY26 Loss Narrows 32.1% to RMB 101 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258376","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258376?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:01","pubTimestamp":1787266863,"startTime":"0","endTime":"0","summary":"Brii Bio H1 FY26 loss narrows 32.1% to RMB 101 millionBrii Bio posted an IFRS net loss of RMB 101 million, narrowing 32.1% from a year earlier; basic loss per share improved to RMB 0.14.Other income f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL4prdW4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137","BK1587","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161721104","title":"Brii Biosciences Sets 20 August 2026 Board Meeting to Review 1H26 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1161721104","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161721104?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:44","pubTimestamp":1786113898,"startTime":"0","endTime":"0","summary":"On 7 August 2026, Brii Biosciences Limited announced that its board of directors will convene on Thursday, 20 August 2026. The agenda includes consideration and approval of the unaudited interim...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657449946","title":"Brii Biosciences Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657449946","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657449946?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:28","pubTimestamp":1786112893,"startTime":"0","endTime":"0","summary":"Brii Biosciences schedules board meeting to review interim resultsBrii Biosciences scheduled a board meeting for Aug. 20, 2026 to review unaudited interim results for the six months ended June 30, 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL6M3pwP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02137","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121418980","title":"Analyzing the First Half Fiscal Revenue and Expenditure Growth Rates in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1121418980","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121418980?lang=en_us&edition=fundamental","pubTime":"2026-07-29 10:41","pubTimestamp":1785292872,"startTime":"0","endTime":"0","summary":"Zhu Qing, a chief professor at the Institute of Fiscal and Public Policy at Renmin University of China, explains that the full-caliber fiscal budget consists of four main components, known as the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","02137","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182017426","title":"Brii Biosciences (BRII-B) Adds 46.56 Thousand New Shares in June; Confirms Public-Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1182017426","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182017426?lang=en_us&edition=fundamental","pubTime":"2026-07-07 17:25","pubTimestamp":1783416359,"startTime":"0","endTime":"0","summary":"Brii Biosciences Limited filed its Monthly Return for Equity Issuer to the Hong Kong Stock Exchange on 7 July 2026, detailing share-capital movements for June 2026. Authorised capital unchanged   •...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648957006","title":"Is Brii Biosciences (HKG:2137) In A Good Position To Deliver On Growth Plans?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648957006","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648957006?lang=en_us&edition=fundamental","pubTime":"2026-07-04 09:10","pubTimestamp":1783127413,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2137/brii-biosciences-shares/news/is-brii-biosciences-hkg2137-in-a-good-position-to-deliver-on","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2137/brii-biosciences-shares/news/is-brii-biosciences-hkg2137-in-a-good-position-to-deliver-on","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1574","BK1587","02137"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.briibio.com","stockEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.1066},{"period":"3month","weight":-0.102},{"period":"6month","weight":-0.4211},{"period":"1year","weight":-0.5769},{"period":"ytd","weight":-0.3759}],"compareEarnings":[{"period":"1week","weight":-0.0195},{"period":"1month","weight":-0.0079},{"period":"3month","weight":0.0173},{"period":"6month","weight":-0.0426},{"period":"1year","weight":-0.0557},{"period":"ytd","weight":-0.0278}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Brii Biosciences Ltd is a biotechnology company primarily engaged in the development of therapies for infectious diseases and central nervous system diseases. The Company's main products include BRII-179, a candidate drug for hepatitis B virus (HBV) immunotherapy, Tobevibart, an investigational neutralizing monoclonal antibody targeting hepatitis B surface antigen (HBsAg), as well as soralimixin (BRII-693), a synthetic lipopeptide for treating multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacterial infections. The Company primarily operates its businesses in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.040695},{"month":2,"riseRate":0.6,"avgChangeRate":0.049398},{"month":3,"riseRate":0.2,"avgChangeRate":-0.163076},{"month":4,"riseRate":0.2,"avgChangeRate":-0.015797},{"month":5,"riseRate":0,"avgChangeRate":-0.081235},{"month":6,"riseRate":0.2,"avgChangeRate":-0.107834},{"month":7,"riseRate":0.8,"avgChangeRate":0.07356},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.000001},{"month":9,"riseRate":0.5,"avgChangeRate":-0.008538},{"month":10,"riseRate":0.2,"avgChangeRate":-0.127852},{"month":11,"riseRate":0.6,"avgChangeRate":0.286305},{"month":12,"riseRate":0.2,"avgChangeRate":-0.154392}],"exchange":"SEHK","name":"BRII-B","nameEN":"BRII-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BRII-B(02137),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BRII-B(02137) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BRII-B,02137,BRII-B股票,BRII-B股票老虎,BRII-B股票老虎国际,BRII-B行情,BRII-B股票行情,BRII-B股价,BRII-B股市,BRII-B股票价格,BRII-B股票交易,BRII-B股票购买,BRII-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BRII-B(02137),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BRII-B(02137) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}